Company: DARE
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0001401914-25-000014
Chunk: 27

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 27
---
,832 shares of common stock issuable upon exercise of stock options.                                                                                                                                                                                                                                                 |
| (5) |     | Consists of 20,313 shares of common stock issuable upon exercise of stock options.                                                                                                                                                                                                                                                 |
| (6) |     | Includes 19,832 shares of common stock issuable upon exercise of stock options. The outstanding shares are held by the Matz Trust Dated December 20, 1999. Mr. Matz is the co-trustee of such trust and has shared investment and dispositive power over such shares.                                                              |
| (7) |     | Includes 20,323 shares of common stock issuable upon exercise of stock options. The outstanding shares are held by William and Marisa Rastetter Trustees of the Rastetter Family Trust U/A Dated 09/02/2010. Dr. Rastetter is the co-trustee of such trust and has shared investment and dispositive power over such shares.       |
| (8) |     | Includes 20,015 shares of common stock issuable upon exercise of stock options. The outstanding shares are held by the Robin J. Steele Trust DTD 1/30/2015. Ms. Steele is the trustee of such trust and has sole investment and dispositive power over such shares.                                                                |
| (9) |     | Includes 337,857 shares of common stock issuable upon exercise of stock options. The members of this group are our two executive officers (Ms. Johnson and Ms. Haring-Layton) and our five non-employee directors (Drs. Grossman, Kelley,  and Rastetter, Mr. Matz, and Ms. Steele).                                               |

2025 Proxy Statement | Page 19

### CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

#### Related Transactions
Except as set forth below, there has not been any transaction since January 1, 2023, nor is there any currently proposed, that requires disclosure Item 404 of Regulation S-K.

In October 2021, we hired the daughter of our Chief Executive Officer as our Project Manager, and before she joined us as an employee, she provided consulting services to us since 2020. Our Chief Executive Officer does not directly supervise or evaluate the performance of her daughter, and the employment relationship we have with her daughter is periodically evaluated by our Audit Committee for, among other purposes, conflicts of interest purposes. We currently pay the daughter of our Chief Executive Officer